Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer immunotherapy using RNA-loaded dendritic cells.

P Ponsaerts1, V F I Van Tendeloo, Z N Berneman

  • 1Laboratory of Experimental Hematology, Faculty of Medicine, University of Antwerp, Antwerp University Hospital, Edegem, Belgium. Peter.Ponsaerts@uza.be

Clinical and Experimental Immunology
|November 25, 2003
PubMed
Summary

Messenger RNA (mRNA)-loaded dendritic cells (DC) efficiently present antigens to stimulate T-cell responses. This approach shows promise for developing novel cancer vaccines and immunotherapy strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Acute hantavirus infection presenting as haemolytic-uraemic syndrome (HUS): the importance of early clinical diagnosis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

Journal of immunology research·2017
Same author

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium.

Leukemia research·2016
Same author

Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.

NeuroImage·2015
Same author

Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?

Multiple sclerosis (Houndmills, Basingstoke, England)·2013

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating immune responses.
  • A key challenge in immunotherapy is effectively delivering antigens to DCs for T-cell stimulation.
  • Major histocompatibility complex (MHC) class I and class II restricted immunity is vital for anti-tumour and anti-viral responses.

Purpose of the Study:

  • To review the development of mRNA-loaded DC-based immunotherapy vaccines.
  • To compare mRNA transfection efficiencies in DCs.
  • To evaluate the capacity of RNA-loaded DCs to activate T-cell responses.

Main Methods:

  • Comparative analysis of published data on mRNA transfection efficiency in DCs.
  • Overview of studies detailing CD8+ and CD4+ T-cell activation by RNA-loaded DCs.

Related Experiment Videos

  • Summarization of in vitro T-cell activation data.

    • Main Results:

    • RNA-loaded DCs efficiently process and present antigenic epitopes.
    • RNA-loaded DCs effectively stimulate primary and secondary in vitro immune responses.
    • Data indicate successful T-cell clone activation using RNA-loaded DCs.

    Conclusions:

    • mRNA-loaded DCs demonstrate efficient antigen presentation and T-cell activation.
    • This strategy holds significant promise for future cancer vaccination.
    • RNA-loaded DCs represent a viable approach for immunotherapy development.